Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing.
Publication
, Journal Article
Burt, T; Noveck, RJ; MacLeod, DB; Layton, AT; Rowland, M; Lappin, G
Published in: Clin Transl Sci
September 2017
Duke Scholars
Published In
Clin Transl Sci
DOI
EISSN
1752-8062
Publication Date
September 2017
Volume
10
Issue
5
Start / End Page
337 / 350
Location
United States
Related Subject Headings
- Translational Research, Biomedical
- Social Control, Formal
- Humans
- General Clinical Medicine
- Drug Development
- Drug Delivery Systems
- Dose-Response Relationship, Drug
- Clinical Trials as Topic
- Animals
- 3214 Pharmacology and pharmaceutical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Burt, T., Noveck, R. J., MacLeod, D. B., Layton, A. T., Rowland, M., & Lappin, G. (2017). Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing. Clin Transl Sci, 10(5), 337–350. https://doi.org/10.1111/cts.12464
Burt, T., R. J. Noveck, D. B. MacLeod, A. T. Layton, M. Rowland, and G. Lappin. “Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing.” Clin Transl Sci 10, no. 5 (September 2017): 337–50. https://doi.org/10.1111/cts.12464.
Burt T, Noveck RJ, MacLeod DB, Layton AT, Rowland M, Lappin G. Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing. Clin Transl Sci. 2017 Sep;10(5):337–50.
Burt, T., et al. “Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing.” Clin Transl Sci, vol. 10, no. 5, Sept. 2017, pp. 337–50. Pubmed, doi:10.1111/cts.12464.
Burt T, Noveck RJ, MacLeod DB, Layton AT, Rowland M, Lappin G. Intra-Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing. Clin Transl Sci. 2017 Sep;10(5):337–350.
Published In
Clin Transl Sci
DOI
EISSN
1752-8062
Publication Date
September 2017
Volume
10
Issue
5
Start / End Page
337 / 350
Location
United States
Related Subject Headings
- Translational Research, Biomedical
- Social Control, Formal
- Humans
- General Clinical Medicine
- Drug Development
- Drug Delivery Systems
- Dose-Response Relationship, Drug
- Clinical Trials as Topic
- Animals
- 3214 Pharmacology and pharmaceutical sciences